Until recently, children and adolescents were not eligible for COVID-19 vaccination. They may have been a considerable source of SARS-CoV-2 spread. We evaluated SARS-CoV-2 IgG antibody seroprevalence in Israeli children aged 0–15 years from January 2020 to March 2021. Seropositivity was 1.8–5.5 times higher than COVID-19 incidence rates based on PCR testing. We found that SARS-CoV-2 infection among children is more prevalent than previously thought and emphasise the importance of seroprevalence studies to accurately estimate exposure.
All Keywords
【저자키워드】 COVID-19, SARS-CoV-2, seroprevalence study, Pfizer-BioNTech vaccine, 【초록키워드】 SARS-COV-2 infection, children, Spread, PCR testing, COVID-19 vaccination, SARS-CoV-2 IgG antibody, Seropositivity, COVID-19 incidence, prevalent, thought, evaluated, eligible, 【제목키워드】 SARS-COV-2 infection, children,
【저자키워드】 COVID-19, SARS-CoV-2, seroprevalence study, Pfizer-BioNTech vaccine, 【초록키워드】 SARS-COV-2 infection, children, Spread, PCR testing, COVID-19 vaccination, SARS-CoV-2 IgG antibody, Seropositivity, COVID-19 incidence, prevalent, thought, evaluated, eligible, 【제목키워드】 SARS-COV-2 infection, children,
최근까지 어린이와 청소년은 COVID-19 예방 접종을 받을 수 없었습니다. 그들은 SARS-CoV-2 확산의 상당한 원천이었을 수 있습니다. 2020년 1월부터 2021년 3월까지 0-15세 이스라엘 어린이의 SARS-CoV-2 IgG 항체 혈청유병률을 평가했습니다. 혈청양성은 PCR 검사를 기반으로 한 COVID-19 발병률보다 1.8-5.5배 높았습니다. 우리는 어린이들 사이에서 SARS-CoV-2 감염이 이전에 생각했던 것보다 더 만연하다는 것을 발견했으며 노출을 정확하게 추정하기 위한 혈청 유병률 연구의 중요성을 강조합니다.